H:TSXHydro One Limited Analysis
Data as of 2026-03-13 - not real-time
CA$60.09
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Hydro One Limited is trading at C$60.09, just below the computed resistance of C$60.19 and well above its 20‑day SMA of C$58.13, indicating a short‑term bullish bias. However, the RSI of 71.2 signals overbought conditions, and the price is more than double the DCF fair value of C$29.82, suggesting a material valuation gap. The MACD remains bullish with the line above the signal, but the histogram is thin, hinting at limited upside momentum. Recent news confirms a quarterly dividend declaration, maintaining a 2.25% yield with a payout ratio near 59%, yet free cash flow is negative, raising sustainability concerns.
Fundamentally, Hydro One delivers solid revenue growth of 8.3% and a respectable operating margin of 19.2%, but its debt‑to‑equity ratio exceeds 150%, and the beta is slightly negative, reflecting low market sensitivity. The utility sector’s regulated nature provides a defensive backdrop, but high leverage and the overvalued price relative to peers (PE 26.9 vs industry 23.3) temper enthusiasm for new buying.
Fundamentally, Hydro One delivers solid revenue growth of 8.3% and a respectable operating margin of 19.2%, but its debt‑to‑equity ratio exceeds 150%, and the beta is slightly negative, reflecting low market sensitivity. The utility sector’s regulated nature provides a defensive backdrop, but high leverage and the overvalued price relative to peers (PE 26.9 vs industry 23.3) temper enthusiasm for new buying.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- RSI overbought at 71
- Price near resistance of C$60.19
- Negative free cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Regulated revenue stream
- Dividend yield of 2.25% with stable payout
- Moderate revenue growth (8.3%)
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt-to-equity (>150%)
- Long‑term utility stability
- Valuation gap versus DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin14.81%
P/E Ratio26.9
ROE10.83%
ROA3.66%
Debt/Equity150.35
P/B Ratio2.8
Op. Cash FlowCA$2.7B
Free Cash FlowCA$-1106375040
Industry P/E23.3
Technical Analysis
TrendBullish
RSI71.2
SupportCA$56.00
ResistanceCA$60.19
MA 20CA$58.13
MA 50CA$55.59
MA 200CA$51.99
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCA$29.82
Target PriceCA$54.11
Upside/Downside-9.96%
GradeOvervalued
TypeBlend
Dividend Yield2.25%
Risk Assessment
Beta-0.16
Volatility14.92%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.